Applied DNA Sciences shares are trading higher by 18.7% during Tuesday's session. The company announced it positioned its TR8 PGx testing as pre-emptive testing for therapeutic safety.
Applied DNA Sciences (APDN) announced that Applied DNA Clinical Labs is repositioning its TR8 PGx pharmacogenomics testing service to offer ...
Fintel reports that on March 28, 2025, BMO Capital upgraded their outlook for Hudson Pacific Properties, Inc. - Preferred ...
Fintel reports that on March 28, 2025, B of A Securities downgraded their outlook for Voya Financial, Inc. - Preferred Stock ...
A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the ...
Detailed price information for Preferred Invesco ETF (PGX-A) from The Globe and Mail including charting and trades.
A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect ...
Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the “Company”), a leader in PCR-based DNA technologies, today announced that Applied DNA Clinical Labs (ADCL), the Company’s wholly-owned ...
Detailed price information for Preferred Invesco ETF (PGX-A) from The Globe and Mail including charting and trades.
Corient Private Wealth LLC boosted its position in shares of Invesco Preferred ETF (NYSEARCA:PGX – Free Report) by 37.0% in ...
HighTower Advisors LLC boosted its stake in Invesco Preferred ETF (NYSEARCA:PGX – Free Report) by 87.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The ...